申请人:Santen Pharmaceutical Co., Ltd.
公开号:US04499102A1
公开(公告)日:1985-02-12
Thiazolidine and pyrrolidine compounds which have the general formula ##STR1## and salts thereof for preventing or relieving diabetic complications and for reducing blood pressure, the processes for their preparation, and the compositions comprising them and pharmaceutically acceptable excipient(s).
具有一般化学式##STR1##的噻唑啉和吡咯烷化合物及其盐,用于预防或缓解糖尿病并降低血压,其制备方法,以及包含它们和药用可接受的赋形剂的组合物。